Extracellular signal-regulated kinase 1/2 and protein phosphatase 2A are involved in the antiproliferative activity of conjugated linoleic acid in MCF-7 cells

British Journal of Nutrition

Volumn 96, Issue 1, 2006, Pages 22-27

  Miglietta, Antonella ^a   Bozzo, Francesca ^a   Gabriel, Ludovica ^a   Bocca, Claudia ^a   Canuto, Rosa Angela ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Conjugated linoleic acid; Extracellular signal Regulated kinase 1 2; MCF 7 cell line; Proliferation; Protein phosphatase 2A

Indexed keywords

CONJUGATED LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LINOLEIC ACIDS, CONJUGATED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; UP-REGULATION;

EID: 33746764999     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20061619     Document Type: Article

References (35)

1. Adeyinka A, Nui Y, Cherlet T, Snell L, Watson P-H & Murphy LC (2002) Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 8, 1747-1753.
2. Belury MA (2002) Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132, 2995-2998.
3. Belury MA, Nickel KP, Bird CE & Wu Y (1996) Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 26, 149-157.
4. Boelsma E, Hendriks HF & Roza L (2001) Nutritional skin care: health effects of micronutrients and fatty acids. Am J Clin Nutr 73, 853-864.
5. Boldt S, Weidle UH & Kolch W (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23, 1831-1838.
6. Brown JM, Boysen MS, Chung S, Fabiyi O, Morrison RF, Mandrup S & McIntosh MK (2004) Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J Biol Chem 279, 26735-26747.
7. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA & McCubrey JA (2003) Signal transduction mediated by the Ras/ Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17, 1263-1293.
8. Cohen P (2000) The regulation of protein function by multisite phosphorylation - a 25 year update. Trends Biochem Sci 25, 596-601.
9. Escrich E, Solanas M, Soler M, Ruiz de Villa MC, Sanchez JA & Segura R (2001) Dietary polyunsaturated n-6 lipids effects on the growth and fatty acid composition of rat mammary tumors. J Nutr Biochem 12, 536-549.
10. Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, Fleischer A & Rebollo A (2003) Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 85, 721-726.
11. Gopalakrishna, R, Gundimeda U, Fontana JA & Clarke R (1999) Differential distribution of protein phosphatase 2A in human breast carcinoma cell lines and its relation to estrogen receptor status. Cancer Lett 136, 143-151.
12. α. Proc Natl Acad Sci U S A 95, 12370-12375.
13. Ip C, Carter CA & Ip MM (1985) Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res 45, 1997-2001.
14. Ip C, Dong Y, Ip MM, Banni S, Carta G, Angioni E, Murru E, Spada S, Melis MP & Saebo A (2002) Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 43, 52-58.
15. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK & Ip C (1999) Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250, 22-34.
16. Jaattela M (2004) Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23, 2746-2756.
17. Janssens V & Goris J (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 353, 417-439.
18. Liu X, Yan S, Zhou T, Terada Y & Erikson RL (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23, 763-776.
19. Maggiora M, Bologna M, Ceru MP, et al. (2004) An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int J Cancer 12, 909-919.
20. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I & Heys SD (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 16, 1447-1449.
21. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ & Sarcevic B (2005) Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 229, 161-173.
22. Miglietta A, Bozzo F, Bocca C, Gabriel L, Trombetta A, Belotti S & Canuto RA (2006) Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett 234, 149-157.
23. Muzio G, Maggiora M, Trombetta A, Martinasso G, Reffo P, Colombatto S & Canute, RA (2003) Mechanisms involved in growth inhibition induced by clofibrate in hepatoma cells. Toxicology 187, 149-159.
24. Ochoa JJ, Farquharson AJ, Grant I, Moffat LE, Heys SD & Wahle KW (2004) Conjugated linoleic acids (CLA's) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25, 1185-1191.
25. Park Y, Allen KG & Shultz TD (2000) Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res 20, 669-676.
26. Reyes N, Reyes I, Tiwari R & Geliebter J (2004) Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett 209, 25-35.
27. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH & Yue W (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80, 239-256.
28. Schonthal AH (2001) Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 170, 1-13.
29. Sebolt-Leopold JS & Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4, 937-947.
30. Shultz TD, Chew BP & Seaman WR (1992) Differential stimulatory and inhibitory responses of human MCF-7 breast cancer cells to linoleic acid and conjugated linoleic acid in culture. Anticancer Res 12, 2143-2145.
31. Stoll BA (2002) N-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br J Nutr 87, 193-198.
32. Whigham LD, Cook ME & Atkinson RL (2000) Conjugated linoleic acid: implications for human health. Pharmacol Res 42, 503-510.
33. Williams R, Sanghera J, Wu F, Carbonaro-Hall D, Campbell DL, Warburton D, Pelech S & Hall F (1993) Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family. J Biol Chem 268, 18213-18217.
34. Zhang L, Bewick M & Lafrenie RM (2002) Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase. Carcinogenesis 23, 1251-1258.
35. Zivadinovic D & Watson CS (2005) Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7, R130-R144.